Cardiovascular

NEBIVOLOL

  • Brand NameOLMEVASC
  • Strength5+20 mg, 5+40 mg, 10+20 mg, 10+40 mg
  • Dosage typeCapsules
  • therapeutic areaCardiovascular

INDICATION

  • To reduce the risk of stroke and systemic embolism in patients with non - valvular atrial fibrillation
  • For treatment of deep vein thrombosis and pulmonary embolism in patients who have been treated with parental anticoagulant for 5 - 10 days
  • To reduce the risk of recurrence of deep vein thrombosis and pulmonary embolism in patients who have been previously treated
  • For the prophylaxis of deep vein thrombolism and pulmonary embolism who have undergone hip replacement surgery